SUBSCRIBE
SUBSCRIBE
News   FDA

AMAG Pharmaceuticals, Inc. Gets FDA Request for More Data on Anemia Drug

October 20, 2008 | 
1 min read
CAMBRIDGE, Mass. - Biotechnology company AMAG Pharmaceuticals Inc. said Monday the Food and Drug Administration wants more information on a prospective anemia drug before considering it for approval.
FDA Approvals Regulatory
MORE ON THIS TOPIC
Money or health. Scale of balance between money, dollar and medicine, pill. Cost of health. Compare of price healthcare and healthy. Seesaw between wealth and healthy. Treatment or savings. Vector.
Approvals
Ultragenyx wins FDA greenlight for first Sanfilippo therapy, priced at nearly $4M
September 18, 2026
 · 
3 min read
 · 
Tristan Manalac
Email envelope with warning sign on white background
Manufacturing
FDA warning letter accuses Bausch & Lomb of lacking commitment to remediation
September 16, 2026
 · 
2 min read
 · 
Nick Paul Taylor
FDA
FDA hears input on psychedelics, PDUFA, lung cancer’s next-gen therapies boost survival
September 16, 2026
 · 
1 min read
 · 
Jef Akst
Creative concept of leadership and innovation with a glowing blue light bulb leading paper planes. Symbol of advanced technology, AI-driven strategy, and visionary direction in a digital future.
Regulatory
FDA opens Operation TrialBlazer for applications, hoping to reshore early trials
September 15, 2026
 · 
1 min read
 · 
Heather McKenzie